Are Shareholders Getting Enough in the Elizabeth Arden Deal?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Are Shareholders Getting Enough in the Elizabeth Arden Deal?

© Thinkstock

Shares of Elizabeth Arden Inc. (NASDAQ: RDEN) skyrocketed early Friday following the announcement that the company will be acquired by Revlon Inc. (NYSE: REV). The companies have signed a definitive agreement under which Revlon will acquire all the outstanding shares of Elizabeth Arden for $14.00 per share in cash, representing an enterprise value for Elizabeth Arden of roughly $870 million.

The transaction was unanimously approved by both boards of directors. It is still subject to Elizabeth Arden shareholder approval, as well as regulatory approval. This deal is expected to close by the end of 2016.

Cost synergies of about $140 million are expected to be achieved through the elimination of duplicative activities, leveraging purchasing scale, and optimizing the manufacturing and distribution networks of the combined company. The companies anticipate that they will achieve additional growth opportunities in both sales channels and geographies.

[nativounit]

Elizabeth Arden has a 50-day moving average of $9.36 and a 200-day moving average of $9.43. Compared to the purchase price, these represent premiums of 49.6% and 48.5%, respectively.

For the year ending in December 2016, the company expects to have an annualized net sales of roughly $3 billion. Revlon expects to generate net sales in the range of $2.0 billion to $2.1 billion in this time as well. The consensus estimates call for a combined net sales of $2.88 billion for both companies, with Revlon’s consensus estimate making up $1.91 billion of the total.

Fabian Garcia, president and CEO of Revlon, commented:

This acquisition is strategically and financially compelling. Elizabeth Arden and Revlon are both known for their iconic brands, entrepreneurial spirit and commitment to innovation, quality and excellence. Revlon plans to build upon Elizabeth Arden’s ongoing transformation by further enhancing the brand, with even more vibrant and relevant product development and marketing, while carefully preserving its unique heritage within prestige. Combining our brands, talent, and global distribution will give our company a significant presence in all major channels and categories, while accelerating sales growth in existing and new geographic regions. We look forward to bringing together our two top-notch teams to form a global leader in beauty.

[wallst_email_signup]

Shares of Elizabeth Arden closed Thursday at $9.31, with a consensus analyst price target of $11.25 and a 52-week trading range of $5.02 to $15.59. Following the announcement of the acquisition, the stock was up nearly 50% at $13.78 in early trading indications Friday.

Revlon shares closed Thursday at $31.15. The consensus price target is $42.00, and the 52-week range is $24.20 to $38.00.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618